Developer docs
API playgroundTry for free, no card

Search company profiles

Softgel Healthcare

Full company profile

uuid000ce8a

Namestring
Softgel Healthcare
Legal namestring
Softgel Healthcare Private Limited
Company typeenum
Private
Founded yearint
2006
Descriptiontext

Softgel Healthcare Private Limited is an India-based, pure-play contract development and manufacturing organization (CDMO) headquartered in Chennai, Tamil Nadu. Founded in 2006 and operating with 800+ employees, the company specializes in the development and production of soft gelatin capsules for global pharmaceutical and nutraceutical clients. Its customer base spans multinational branded pharma, generic pharma, consumer health, and major pharmacy retailers, with named relationships including Pfizer, Abbott, Viatris, Sandoz, Sun Pharma, Cipla, Mankind Pharma, Apotex, Jamp Pharma, Unilab, Walgreens, CVS, P&G, Reckitt Benckiser, and GNC. The company generates revenue through negotiated, per-project contract manufacturing fees for formulation development, scale-up, commercial manufacturing, and packaging, targeting Rx and OTC pharmaceutical and nutraceutical buyers across 60+ countries.

The company's technical platform is built around automated, servo-controlled high-speed softgel encapsulation equipment sourced from Sky Softgel Korea, fully automated visual inspection systems, and dedicated suites for high-potency molecules and hormones with specialized containment. It operates 21 CFR Part 11 compliant laboratory systems and supports multiple packaging formats including blisters, alu-alu, bottles, and bulk foil with serialization compatible with US FDA and EU markets. Quality and regulatory compliance are anchored by a broad set of accreditations covering FDA, EU GMP, TGA, Health Canada, ANVISA, INVIMA, NAFDAC, FSSAI, ISO 9001/14001/13485, EU MDR, and CMMC Level 2, giving the firm permission to manufacture for most major regulated pharmaceutical markets. The product catalog covers 25+ formulations spanning oncology (Enzalutamide, Midostaurin), cardiovascular (Icosapent Ethyl, Dutasteride), pain management (Ibuprofen, Paracetamol/Acetaminophen), dermatology (Isotretinoin), immunology (Voclosporin, Avacopan), and nutritional supplements (Vitamin D3, Alfacalcidol, Calcitriol). Commercialization runs through two brand surfaces: SHPL for Rx/OTC and Valdoza for nutraceuticals.

The business is founder-managed, with A.M. Sulaiman as Managing Director and supported by a Scientific Advisory Board that includes Dr. Arjun Oberoi (healthcare investment), Guru Ramanathan (former GNC CIO), and Kimberlee Steel (former Catalent BD). Go-to-market is enterprise B2B field sales through a global chief business officer and four regional business development officers covering South East Asia, Middle East & Europe, Eastern Europe, and LATAM. The company has pursued ESG positioning via a Power Purchase Agreement with Radiance Renewables projected to abate roughly 130,000 tonnes of CO2 over the agreement life, and a recent (2025) cross-border discovery proceeding in the Madras High Court and Supreme Court of India against a Pfizer-issued Letter Rogatory from a US Delaware court. Ownership, funding history, and detailed financials are not disclosed in the source material.

Short descriptiontext

Softgel Healthcare is an Indian CDMO based in Chennai that develops and manufactures softgel capsules for global pharmaceutical and nutraceutical companies. It operates 800+ employees, multi-regulatory accreditations, and serves 60+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersChennai, India
HQ citystring
Chennai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
softgel capsule manufacturing, pharmaceutical contract manufacturing, nutraceutical production, high-potency drug manufacturing, CDMO formulation services
Industry2 codes
1Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
CodeHLAGABABPrimaryYes
2Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
CodeHLAGABAJPrimaryNo
SIC code2 codes
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Health Services8000
Product category
Pharmaceutical Contract Manufacturing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Manufacturing Services
TypeManaged Services
Description

As a pure-play CDMO (Contract Development and Manufacturing Organization), Softgel Healthcare generates revenue through contract manufacturing of softgel capsules for pharmaceutical and nutraceutical products. The company develops and manufactures products for clients under non-compete agreements, providing end-to-end services from product development to manufacturing and packaging.

softgelhealthcare.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Valdoza
Description

Nutraceuticals product brand under Softgel Healthcare

softgelhealthcare.com
Core offering1 text field

Softgel Healthcare is a pure-play Contract Development and Manufacturing Organization (CDMO) that develops and manufactures soft gelatin capsules for pharmaceutical and nutraceutical clients globally. It provides end-to-end services from formulation development and analytical R&D to manufacturing, packaging (bottles, blister, alu-alu, bulk foil) with serialization, regulatory affairs support, and clinical studies assistance, serving clients under non-compete agreements across 60+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Avoids approximately 130,000 tonnes of carbon dioxide emissions over PPA agreement life
+1 more record
Product overview1 text field

Softgel Healthcare is a contract development and manufacturing organization (CDMO) specializing in softgel capsule manufacturing. The company operates two product brands: SHPL for Rx and OTC pharmaceutical products, and Valdoza for nutraceuticals. Their portfolio comprises 24 distinct softgel capsule products spanning therapeutic categories including oncology (Enzalutamide, Midostaurin), cardiovascular (Icosapent Ethyl), dermatology (Isotretinoin), pain management (Ibuprofen, Paracetamol/Acetaminophen), vitamins and supplements (Vitamin D3, Alfacalcidol, Calcitriol), and various OTC treatments. The company also offers pharmaceutical manufacturing services including quality management, logistics, regulatory services, manufacturing and packaging, sourcing, project management, and clinical studies. Packaging options include Clear Bottle, Blister in Carton, White Bottle, Alu Alu, Grey Foil Bulk Packing, and Blister in Pouch formats.

Product and service32 records
1Enzalutamide Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Enzalutamide softgel capsules, an Rx pharmaceutical product, for global pharmaceutical company clients under CDMO arrangements.

2Cyclosporine Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Cyclosporine softgel capsules, an Rx pharmaceutical product, for global pharmaceutical company clients under CDMO arrangements.

3Tafamidis Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Tafamidis softgel capsules, an Rx pharmaceutical product, for global pharmaceutical company clients under CDMO arrangements.

4Nintedanib Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Nintedanib softgel capsules, an Rx pharmaceutical product, for global pharmaceutical company clients under CDMO arrangements.

5Ibuprofen Softgel Capsule (Regular and Minis)
CategoryRx/OTC Pharmaceutical
Description

Contract manufacturing of Ibuprofen softgel capsules in regular and mini sizes for pain relief, available for both Rx and OTC pharmaceutical clients.

6Paracetamol and Ibuprofen Combination Softgel Capsule
CategoryOTC Pharmaceutical
Description

Contract manufacturing of a fixed-dose combination Paracetamol and Ibuprofen softgel capsule formulation as an OTC analgesic product.

7Acetaminophen Softgel Capsule
CategoryOTC Pharmaceutical
Description

Contract manufacturing of Acetaminophen softgel capsules for pain relief and fever reduction as an OTC pharmaceutical product.

8Ethosuximide Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Ethosuximide softgel capsules for anti-epileptic use as an Rx pharmaceutical product.

9Isotretinoin Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Isotretinoin softgel capsules for acne treatment as an Rx pharmaceutical product.

10Vitamin D3 Softgel Capsule
CategoryNutraceutical
Description

Contract manufacturing of Vitamin D3 softgel capsules as a nutraceutical dietary supplement product.

11Alfacalcidol Softgel Capsule
CategoryNutraceutical
Description

Contract manufacturing of Alfacalcidol softgel capsules, a vitamin D analog, as a nutraceutical dietary supplement product.

12Calcitriol Softgel Capsule
CategoryNutraceutical
Description

Contract manufacturing of Calcitriol softgel capsules, the active form of Vitamin D3, as a nutraceutical dietary supplement product.

13Icosapent Ethyl Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Icosapent Ethyl softgel capsules, an omega-3 fatty acid for cardiovascular health, as an Rx pharmaceutical product.

14Dutasteride Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Dutasteride softgel capsules, a 5-alpha-reductase inhibitor, as an Rx pharmaceutical product.

15Diphenhydramine Hydrochloride Softgel Capsule
CategoryOTC Pharmaceutical
Description

Contract manufacturing of Diphenhydramine Hydrochloride softgel capsules as an OTC antihistamine product.

16Loperamide Hydrochloride Softgel Capsule
CategoryOTC Pharmaceutical
Description

Contract manufacturing of Loperamide Hydrochloride softgel capsules as an OTC anti-diarrheal product.

17Midostaurin Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Midostaurin softgel capsules as a targeted therapy Rx pharmaceutical product, including for oncology indications.

18Sennosides Softgel Capsule
CategoryOTC Pharmaceutical
Description

Contract manufacturing of Sennosides softgel capsules as an OTC laxative product.

19Simethicone Softgel Capsule
CategoryOTC Pharmaceutical
Description

Contract manufacturing of Simethicone softgel capsules as an OTC anti-gas product.

20Docusate Sodium Softgel Capsule
CategoryOTC Pharmaceutical
Description

Contract manufacturing of Docusate Sodium softgel capsules as an OTC stool softener product.

21Avacopan Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Avacopan softgel capsules, a complement C5a receptor antagonist, as an Rx pharmaceutical product.

22Voclosporin Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Voclosporin softgel capsules as an Rx immunosuppressant pharmaceutical product.

23Benzonatate Softgel Capsule
CategoryOTC Pharmaceutical
Description

Contract manufacturing of Benzonatate softgel capsules as an OTC cough suppressant product.

24Valporic Softgel Capsule
CategoryRx Pharmaceutical
Description

Contract manufacturing of Valporic softgel capsules as an Rx pharmaceutical product.

25SHPL Rx and OTC Pharmaceutical Product Catalog
CategoryProduct Catalog
Description

Official product catalog from Softgel Healthcare listing the full range of Rx and OTC pharmaceutical softgel capsule products manufactured under the SHPL brand via CDMO engagements.

26Valdoza Nutraceutical Product Catalog
CategoryProduct Catalog
Description

Official product catalog for the Valdoza sub-brand of Softgel Healthcare, listing nutraceutical softgel capsule products including vitamins and dietary supplements.

27Clear Bottle Packaging
CategoryPackaging Option
Description

Contract packaging of softgel capsules in clear bottle format as a finishing option for CDMO customers.

28Blister in Carton Packaging
CategoryPackaging Option
Description

Contract packaging of softgel capsules in blister packs within cartons, with serialization support per US FDA and EU norms, as a finishing option for CDMO customers.

29White Bottle Packaging
CategoryPackaging Option
Description

Contract packaging of softgel capsules in white bottle format as a finishing option for CDMO customers.

30Alu Alu Packaging
CategoryPackaging Option
Description

Contract packaging of softgel capsules in alu-alu blister format for enhanced protection as a finishing option for CDMO customers.

31Grey Foil Bulk Packing
CategoryPackaging Option
Description

Contract bulk packaging of softgel capsules in grey foil format for high-volume distribution as a finishing option for CDMO customers.

32Blister in Pouch Packaging
CategoryPackaging Option
Description

Contract packaging of softgel capsules in blister packs within pouches as a finishing option for CDMO customers.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-12
Description

Radiance Renewables signed a Power Purchase Agreement (PPA) with Softgel Healthcare to supply green power to the healthcare manufacturer's operations in India. The project is expected to avoid approximately 130,000 tonnes of carbon dioxide emissions over the life of the agreement, equivalent to planting around 270,000 trees, while also conserving more than 314,000 cubic metres of water. The partnership reflects the growing momentum among Indian industries to decarbonize operations through renewable energy adoption.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

China-based CDMO offering softgel, gummy, and other dosage forms to global pharma and nutraceutical brands. Closely comparable to Softgel in softgel CDMO services, end-to-end development model, and global customer footprint.

TypeBroad incumbent
Description

Large global CDMO offering a broad range of services including API, drug product, and clinical services. Comparable as a competing CDMO for global pharma customers, though softgel is not its primary dosage form focus.

TypeBroad incumbent
Description

Global CDMO offering API, drug product, and packaging services including softgel capabilities. Comparable as a competing CDMO for development and commercial manufacturing outsourcing decisions.

TypeBroad incumbent
Description

Major global CDMO (part of Thermo Fisher) offering softgel manufacturing as part of a much broader services portfolio. Comparable as a competing CDMO for the same global pharma customers Softgel targets.

TypeDirect peer
Description

European-headquartered CDMO with significant softgel manufacturing capabilities, serving pharma and consumer health customers globally. Direct competitor to Softgel in oral solid softgel CDMO services and primary packaging.

TypeDirect peer
Description

Latin American integrated pharmaceutical and softgel CDMO with global brand operations. Comparable to Softgel in softgel manufacturing, pharmaceutical and nutraceutical customers, and international distribution.

TypeDirect peer
Description

Global pure-play CDMO (now owned by Novo Holdings) with one of the largest softgel encapsulation capacities in the world. Directly comparable to Softgel Healthcare in dosage form, target customers (global pharma), and end-to-end development-to-commercial services.

TypeRegional player
Description

Large Indian pharmaceutical manufacturer with CDMO services and global generics footprint including softgel products. Comparable to Softgel in India-based manufacturing scale, generic pharma customer base, and regulated-market approvals.

TypeBroad incumbent
Description

India-headquartered global CDMO offering drug substance, drug product, and biologics services with a global customer base. Comparable as a competing India-rooted CDMO for global pharma outsourcing, though significantly broader in scope than Softgel.

TypeDirect peer
Description

Canadian specialty CDMO focused on liquid and semi-solid softgel dosage forms for global pharma. Direct peer in softgel contract development and manufacturing for Rx and OTC products.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Softgel Healthcare

Pharmaceutical Contract Manufacturingsoftgelhealthcare.com

Softgel Healthcare is an Indian CDMO based in Chennai that develops and manufactures softgel capsules for global pharmaceutical and nutraceutical companies. It operates 800+ employees, multi-regulatory accreditations, and serves 60+ countries.

What Softgel Healthcare does

Softgel Healthcare Private Limited is an India-based, pure-play contract development and manufacturing organization (CDMO) headquartered in Chennai, Tamil Nadu. Founded in 2006 and operating with 800+ employees, the company specializes in the development and production of soft gelatin capsules for global pharmaceutical and nutraceutical clients. Its customer base spans multinational branded pharma, generic pharma, consumer health, and major pharmacy retailers, with named relationships including Pfizer, Abbott, Viatris, Sandoz, Sun Pharma, Cipla, Mankind Pharma, Apotex, Jamp Pharma, Unilab, Walgreens, CVS, P&G, Reckitt Benckiser, and GNC. The company generates revenue through negotiated, per-project contract manufacturing fees for formulation development, scale-up, commercial manufacturing, and packaging, targeting Rx and OTC pharmaceutical and nutraceutical buyers across 60+ countries.

The company's technical platform is built around automated, servo-controlled high-speed softgel encapsulation equipment sourced from Sky Softgel Korea, fully automated visual inspection systems, and dedicated suites for high-potency molecules and hormones with specialized containment. It operates 21 CFR Part 11 compliant laboratory systems and supports multiple packaging formats including blisters, alu-alu, bottles, and bulk foil with serialization compatible with US FDA and EU markets. Quality and regulatory compliance are anchored by a broad set of accreditations covering FDA, EU GMP, TGA, Health Canada, ANVISA, INVIMA, NAFDAC, FSSAI, ISO 9001/14001/13485, EU MDR, and CMMC Level 2, giving the firm permission to manufacture for most major regulated pharmaceutical markets. The product catalog covers 25+ formulations spanning oncology (Enzalutamide, Midostaurin), cardiovascular (Icosapent Ethyl, Dutasteride), pain management (Ibuprofen, Paracetamol/Acetaminophen), dermatology (Isotretinoin), immunology (Voclosporin, Avacopan), and nutritional supplements (Vitamin D3, Alfacalcidol, Calcitriol). Commercialization runs through two brand surfaces: SHPL for Rx/OTC and Valdoza for nutraceuticals.

The business is founder-managed, with A.M. Sulaiman as Managing Director and supported by a Scientific Advisory Board that includes Dr. Arjun Oberoi (healthcare investment), Guru Ramanathan (former GNC CIO), and Kimberlee Steel (former Catalent BD). Go-to-market is enterprise B2B field sales through a global chief business officer and four regional business development officers covering South East Asia, Middle East & Europe, Eastern Europe, and LATAM. The company has pursued ESG positioning via a Power Purchase Agreement with Radiance Renewables projected to abate roughly 130,000 tonnes of CO2 over the agreement life, and a recent (2025) cross-border discovery proceeding in the Madras High Court and Supreme Court of India against a Pfizer-issued Letter Rogatory from a US Delaware court. Ownership, funding history, and detailed financials are not disclosed in the source material.

Softgel Healthcare firmographics

Firmographics
Name
Softgel Healthcare
Legal name
Softgel Healthcare Private Limited
Website
https://softgelhealthcare.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Softgel Healthcare is an Indian CDMO based in Chennai that develops and manufactures softgel capsules for global pharmaceutical and nutraceutical companies. It operates 800+ employees, multi-regulatory accreditations, and serves 60+ countries.
Ownership category
akta.pro rank

Softgel Healthcare industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing
SIC
Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)
akta.pro primary industry
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
akta.pro secondary industry
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ)

Keywords

  • Softgel capsule manufacturing
  • Pharmaceutical contract manufacturing
  • Nutraceutical production
  • High-potency drug manufacturing
  • CDMO formulation services

Where Softgel Healthcare is headquartered

Location

Headquarters

HQ city
Chennai
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Softgel Healthcare business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Contract Manufacturing Services: As a pure-play CDMO (Contract Development and Manufacturing Organization), Softgel Healthcare generates revenue through contract manufacturing of softgel capsules for pharmaceutical and nutraceutical products. The company develops and manufactures products for clients under non-compete agreements, providing end-to-end services from product development to manufacturing and packaging.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Softgel Healthcare product offering

Product offering

Core offering

Softgel Healthcare is a pure-play Contract Development and Manufacturing Organization (CDMO) that develops and manufactures soft gelatin capsules for pharmaceutical and nutraceutical clients globally. It provides end-to-end services from formulation development and analytical R&D to manufacturing, packaging (bottles, blister, alu-alu, bulk foil) with serialization, regulatory affairs support, and clinical studies assistance, serving clients under non-compete agreements across 60+ countries.

Product overview

Softgel Healthcare is a contract development and manufacturing organization (CDMO) specializing in softgel capsule manufacturing. The company operates two product brands: SHPL for Rx and OTC pharmaceutical products, and Valdoza for nutraceuticals. Their portfolio comprises 24 distinct softgel capsule products spanning therapeutic categories including oncology (Enzalutamide, Midostaurin), cardiovascular (Icosapent Ethyl), dermatology (Isotretinoin), pain management (Ibuprofen, Paracetamol/Acetaminophen), vitamins and supplements (Vitamin D3, Alfacalcidol, Calcitriol), and various OTC treatments. The company also offers pharmaceutical manufacturing services including quality management, logistics, regulatory services, manufacturing and packaging, sourcing, project management, and clinical studies. Packaging options include Clear Bottle, Blister in Carton, White Bottle, Alu Alu, Grey Foil Bulk Packing, and Blister in Pouch formats.

Differentiator

Problem solved

Functional benefit

Brands

  • Valdoza: Nutraceuticals product brand under Softgel Healthcare

Products and services

  • Enzalutamide Softgel Capsule Contract manufacturing of Enzalutamide softgel capsules, an Rx pharmaceutical product, for global pharmaceutical company clients under CDMO arrangements.
  • Cyclosporine Softgel Capsule Contract manufacturing of Cyclosporine softgel capsules, an Rx pharmaceutical product, for global pharmaceutical company clients under CDMO arrangements.
  • Tafamidis Softgel Capsule Contract manufacturing of Tafamidis softgel capsules, an Rx pharmaceutical product, for global pharmaceutical company clients under CDMO arrangements.
  • Nintedanib Softgel Capsule Contract manufacturing of Nintedanib softgel capsules, an Rx pharmaceutical product, for global pharmaceutical company clients under CDMO arrangements.
  • Ibuprofen Softgel Capsule (Regular and Minis) Contract manufacturing of Ibuprofen softgel capsules in regular and mini sizes for pain relief, available for both Rx and OTC pharmaceutical clients.
  • Paracetamol and Ibuprofen Combination Softgel Capsule Contract manufacturing of a fixed-dose combination Paracetamol and Ibuprofen softgel capsule formulation as an OTC analgesic product.
  • Acetaminophen Softgel Capsule Contract manufacturing of Acetaminophen softgel capsules for pain relief and fever reduction as an OTC pharmaceutical product.
  • Ethosuximide Softgel Capsule Contract manufacturing of Ethosuximide softgel capsules for anti-epileptic use as an Rx pharmaceutical product.
  • Isotretinoin Softgel Capsule Contract manufacturing of Isotretinoin softgel capsules for acne treatment as an Rx pharmaceutical product.
  • Vitamin D3 Softgel Capsule Contract manufacturing of Vitamin D3 softgel capsules as a nutraceutical dietary supplement product.
  • Alfacalcidol Softgel Capsule Contract manufacturing of Alfacalcidol softgel capsules, a vitamin D analog, as a nutraceutical dietary supplement product.
  • Calcitriol Softgel Capsule Contract manufacturing of Calcitriol softgel capsules, the active form of Vitamin D3, as a nutraceutical dietary supplement product.
  • Icosapent Ethyl Softgel Capsule Contract manufacturing of Icosapent Ethyl softgel capsules, an omega-3 fatty acid for cardiovascular health, as an Rx pharmaceutical product.
  • Dutasteride Softgel Capsule Contract manufacturing of Dutasteride softgel capsules, a 5-alpha-reductase inhibitor, as an Rx pharmaceutical product.
  • Diphenhydramine Hydrochloride Softgel Capsule Contract manufacturing of Diphenhydramine Hydrochloride softgel capsules as an OTC antihistamine product.
  • Loperamide Hydrochloride Softgel Capsule Contract manufacturing of Loperamide Hydrochloride softgel capsules as an OTC anti-diarrheal product.
  • Midostaurin Softgel Capsule Contract manufacturing of Midostaurin softgel capsules as a targeted therapy Rx pharmaceutical product, including for oncology indications.
  • Sennosides Softgel Capsule Contract manufacturing of Sennosides softgel capsules as an OTC laxative product.
  • Simethicone Softgel Capsule Contract manufacturing of Simethicone softgel capsules as an OTC anti-gas product.
  • Docusate Sodium Softgel Capsule Contract manufacturing of Docusate Sodium softgel capsules as an OTC stool softener product.
  • Avacopan Softgel Capsule Contract manufacturing of Avacopan softgel capsules, a complement C5a receptor antagonist, as an Rx pharmaceutical product.
  • Voclosporin Softgel Capsule Contract manufacturing of Voclosporin softgel capsules as an Rx immunosuppressant pharmaceutical product.
  • Benzonatate Softgel Capsule Contract manufacturing of Benzonatate softgel capsules as an OTC cough suppressant product.
  • Valporic Softgel Capsule Contract manufacturing of Valporic softgel capsules as an Rx pharmaceutical product.
  • SHPL Rx and OTC Pharmaceutical Product Catalog Official product catalog from Softgel Healthcare listing the full range of Rx and OTC pharmaceutical softgel capsule products manufactured under the SHPL brand via CDMO engagements.
  • Valdoza Nutraceutical Product Catalog Official product catalog for the Valdoza sub-brand of Softgel Healthcare, listing nutraceutical softgel capsule products including vitamins and dietary supplements.
  • Clear Bottle Packaging Contract packaging of softgel capsules in clear bottle format as a finishing option for CDMO customers.
  • Blister in Carton Packaging Contract packaging of softgel capsules in blister packs within cartons, with serialization support per US FDA and EU norms, as a finishing option for CDMO customers.
  • White Bottle Packaging Contract packaging of softgel capsules in white bottle format as a finishing option for CDMO customers.
  • Alu Alu Packaging Contract packaging of softgel capsules in alu-alu blister format for enhanced protection as a finishing option for CDMO customers.
  • Grey Foil Bulk Packing Contract bulk packaging of softgel capsules in grey foil format for high-volume distribution as a finishing option for CDMO customers.
  • Blister in Pouch Packaging Contract packaging of softgel capsules in blister packs within pouches as a finishing option for CDMO customers.

Quantifiable outcome

  • Avoids approximately 130,000 tonnes of carbon dioxide emissions over PPA agreement life
  • +1 more outcomes

Companies that use Softgel Healthcare

Customer profile

Named customers15 records

Segments3 records

Ideal customer profiles2 records

Softgel Healthcare technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Softgel Healthcare partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Radiance RenewablescoreStrategic or Co-development Partner · 12 June 2026Radiance Renewables signed a Power Purchase Agreement (PPA) with Softgel Healthcare to supply green power to the healthcare manufacturer's operations in India. The project is expected to avoid approximately 130,000 tonnes of carbon dioxide emissions over the life of the agreement, equivalent to planting around 270,000 trees, while also conserving more than 314,000 cubic metres of water. The partnership reflects the growing momentum among Indian industries to decarbonize operations through renewable energy adoption.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Softgel Healthcare competitors and assessment

Company assessment

Direct peers

  • Sirio Pharma: China-based CDMO offering softgel, gummy, and other dosage forms to global pharma and nutraceutical brands. Closely comparable to Softgel in softgel CDMO services, end-to-end development model, and global customer footprint.
  • Aenova Group: European-headquartered CDMO with significant softgel manufacturing capabilities, serving pharma and consumer health customers globally. Direct competitor to Softgel in oral solid softgel CDMO services and primary packaging.
  • Procaps Group: Latin American integrated pharmaceutical and softgel CDMO with global brand operations. Comparable to Softgel in softgel manufacturing, pharmaceutical and nutraceutical customers, and international distribution.
  • Catalent: Global pure-play CDMO (now owned by Novo Holdings) with one of the largest softgel encapsulation capacities in the world. Directly comparable to Softgel Healthcare in dosage form, target customers (global pharma), and end-to-end development-to-commercial services.
  • Contract Pharmaceuticals: Canadian specialty CDMO focused on liquid and semi-solid softgel dosage forms for global pharma. Direct peer in softgel contract development and manufacturing for Rx and OTC products.

Broad incumbents

  • Almac Group: Large global CDMO offering a broad range of services including API, drug product, and clinical services. Comparable as a competing CDMO for global pharma customers, though softgel is not its primary dosage form focus.
  • Eurofins CDMO: Global CDMO offering API, drug product, and packaging services including softgel capabilities. Comparable as a competing CDMO for development and commercial manufacturing outsourcing decisions.
  • Patheon (Thermo Fisher Scientific): Major global CDMO (part of Thermo Fisher) offering softgel manufacturing as part of a much broader services portfolio. Comparable as a competing CDMO for the same global pharma customers Softgel targets.
  • Piramal Pharma Solutions: India-headquartered global CDMO offering drug substance, drug product, and biologics services with a global customer base. Comparable as a competing India-rooted CDMO for global pharma outsourcing, though significantly broader in scope than Softgel.

Regional players

  • Aurobindo Pharma: Large Indian pharmaceutical manufacturer with CDMO services and global generics footprint including softgel products. Comparable to Softgel in India-based manufacturing scale, generic pharma customer base, and regulated-market approvals.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Softgel Healthcare compliance and trust

Trust signal

Compliance8 records

Softgel Healthcare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Softgel Healthcare leadership team

Management profile

Number of profiles

Profiles9 records

Softgel Healthcare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Softgel Healthcare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Softgel Healthcare

What does Softgel Healthcare do?

Softgel Healthcare is a pure-play Contract Development and Manufacturing Organization (CDMO) that develops and manufactures soft gelatin capsules for pharmaceutical and nutraceutical clients globally. It provides end-to-end services from formulation development and analytical R&D to manufacturing, packaging (bottles, blister, alu-alu, bulk foil) with serialization, regulatory affairs support, and clinical studies assistance, serving clients under non-compete agreements across 60+ countries.

Is Softgel Healthcare a public or private company?

Softgel Healthcare is a private company. It is classified as unknown and is currently operating.

When was Softgel Healthcare founded?

Softgel Healthcare was founded in 2006. It employs 501 to 1,000 people.

Where is Softgel Healthcare based?

Softgel Healthcare is headquartered in Chennai, India, in the Asia region.

How does Softgel Healthcare make money?

One revenue line is on record: contract Manufacturing Services.

Who are Softgel Healthcare's main competitors?

Direct peers on record are Sirio Pharma, Aenova Group, Procaps Group, Catalent and Contract Pharmaceuticals. Broad incumbents are Almac Group, Eurofins CDMO, Patheon (Thermo Fisher Scientific) and Piramal Pharma Solutions. Aurobindo Pharma is listed as a regional player.

Does Softgel Healthcare have an API?

No public API is recorded for Softgel Healthcare.

What industry is Softgel Healthcare in?

Softgel Healthcare's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SolarQuarterRadiance Renewables Signs Green Power PPA with Softgel Healthcare, Aiming to Avoid 130,000 Tonnes of CO₂ EmissionsRadiance Renewables has signed a Power Purchase Agreement (PPA) with Softgel Healthcare Private Limited to supply green power to the healthcare manufacturer's operations in India. The project is expected to avoid approximately 130,000 tonnes of carbon dioxide emissions over the life of the agreement, equivalent to planting around 270,000 trees, while also conserving more than 314,000 cubic metres of water. The partnership reflects the growing momentum among Indian industries to decarbonize operations through renewable energy adoption.JD SupraIndia Just Redrew the Map on Cross-Border DiscoveryOn November 25, 2025, the Madras High Court's Division Bench in Softgel Healthcare Private Limited v. Pfizer Inc. refused to execute Letters Rogatory from a U.S. federal court in Delaware, finding independent grounds to refuse under four separate provisions of the Hague Evidence Convention. The Supreme Court of India subsequently took up the appeal, directed the Union of India to join as a party, and signaled its intent to settle the law on how Indian courts handle foreign discovery requests. If the Supreme Court upholds or narrows the ruling without overturning its core reasoning, it could fundamentally reshape cross-border evidence collection for any matter involving Indian entities and electronically stored information held in India.Business StandardSC flags lack of reciprocity as foreign courts seek data from IndiaThe Supreme Court of India on Thursday questioned the asymmetry in international judicial cooperation while hearing a petition by US pharmaceutical company Pfizer challenging a Madras High Court order that refused to enforce letters rogatory issued by a US court. The letters rogatory sought documents and testimony from Chennai-based Softgel Healthcare. The court observed that foreign authorities readily seek information from India but the same willingness is not always evident when Indian entities make similar requests.MintEverstone Capital acquires controlling stake in Softgel HealthcareEverstone Capital has acquired a controlling stake in Softgel Healthcare (SHPL), a Chennai-based manufacturer of nutraceuticals and pharmaceuticals, in a transaction valuing the company at $125 million. The acquisition positions SHPL for global expansion as a contract research, development, and manufacturing organization with significant export operations. Veda Corporate Advisors served as the exclusive financial advisor for the deal.